192 related articles for article (PubMed ID: 32429657)
1. Liver involvement in NGLY1 congenital disorder of deglycosylation.
Lipiński P; Cielecka-Kuszyk J; Socha P; Tylki-Szymańska A
Pol J Pathol; 2020; 71(1):66-68. PubMed ID: 32429657
[TBL] [Abstract][Full Text] [Related]
2. [Congenital disorder of deglycosylation associated with N-glycanse 1 deficiency].
Lipiński P; Tylki-Szymańska A
Postepy Biochem; 2020 Mar; 66(1):38-41. PubMed ID: 33320481
[TBL] [Abstract][Full Text] [Related]
3. Expanding the NGLY1 deficiency phenotype: Case report of an atypical patient.
Nolan DK; Pastore MT; McBride KL
Eur J Med Genet; 2022 Aug; 65(8):104558. PubMed ID: 35779835
[TBL] [Abstract][Full Text] [Related]
4. NGLY1 deficiency: Novel variants and literature review.
Kariminejad A; Shakiba M; Shams M; Namiranian P; Eghbali M; Talebi S; Makvand M; Jaeken J; Najmabadi H; Hennekam RC
Eur J Med Genet; 2021 Mar; 64(3):104146. PubMed ID: 33497766
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disorder of Deglycosylation.
Miao X; Wu J; Chen H; Lu G
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565658
[TBL] [Abstract][Full Text] [Related]
6. Two novel compound heterozygous mutations in NGLY1as a cause of congenital disorder of deglycosylation: a case presentation.
Ge H; Wu Q; Lu H; Huang Y; Zhou T; Tan D; ZhongqinJin
BMC Med Genet; 2020 Jun; 21(1):135. PubMed ID: 32576142
[TBL] [Abstract][Full Text] [Related]
7. Acute liver failure in a male patient with NGLY1-congenital disorder of deglycosylation.
Rios-Flores IM; Bonal-Pérez MÁ; Castellanos-González A; Velez-Gómez E; Bertoli-Avella AM; Bobadilla-Morales L; Peña-Padilla C; Appendini-Andrade V; Corona-Rivera A; Romero-Valenzuela I; Corona-Rivera JR
Eur J Med Genet; 2020 Aug; 63(8):103952. PubMed ID: 32422350
[TBL] [Abstract][Full Text] [Related]
8. Unexplained death in patients with NGLY1 mutations may be explained by adrenal insufficiency.
van Keulen BJ; Rotteveel J; Finken MJJ
Physiol Rep; 2019 Feb; 7(3):e13979. PubMed ID: 30740912
[TBL] [Abstract][Full Text] [Related]
9. Novel NGLY1 gene variants in Chinese children with global developmental delay, microcephaly, hypotonia, hypertransaminasemia, alacrimia, and feeding difficulty.
Abuduxikuer K; Zou L; Wang L; Chen L; Wang JS
J Hum Genet; 2020 Apr; 65(4):387-396. PubMed ID: 31965062
[TBL] [Abstract][Full Text] [Related]
10. Assay for the peptide:N-glycanase/NGLY1 and disease-specific biomarkers for diagnosing NGLY1 deficiency.
Hirayama H; Suzuki T
J Biochem; 2022 Feb; 171(2):169-176. PubMed ID: 34791337
[TBL] [Abstract][Full Text] [Related]
11. An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene.
Yang S; Cheng YS; Li R; Pradhan M; Hong J; Beers J; Zou J; Liu C; Might M; Rodems S; Zheng W
Stem Cell Res; 2019 Aug; 39():101496. PubMed ID: 31326749
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches.
Owings KG; Lowry JB; Bi Y; Might M; Chow CY
Hum Mol Genet; 2018 Mar; 27(6):1055-1066. PubMed ID: 29346549
[TBL] [Abstract][Full Text] [Related]
13. N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity.
Tambe MA; Ng BG; Freeze HH
Cell Rep; 2019 Dec; 29(13):4620-4631.e4. PubMed ID: 31875565
[TBL] [Abstract][Full Text] [Related]
14. N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1.
Yang K; Huang R; Fujihira H; Suzuki T; Yan N
J Exp Med; 2018 Oct; 215(10):2600-2616. PubMed ID: 30135079
[TBL] [Abstract][Full Text] [Related]
15. JF1/B6F1 Ngly1
Asahina M; Fujinawa R; Fujihira H; Masahara-Negishi Y; Andou T; Tozawa R; Suzuki T
Proc Jpn Acad Ser B Phys Biol Sci; 2021; 97(2):89-102. PubMed ID: 33563880
[TBL] [Abstract][Full Text] [Related]
16. GlcNAc-Asn is a biomarker for NGLY1 deficiency.
Mueller WF; Zhu L; Tan B; Dwight S; Beahm B; Wilsey M; Wechsler T; Mak J; Cowan T; Pritchett J; Taylor E; Crawford BE
J Biochem; 2022 Feb; 171(2):177-186. PubMed ID: 34697629
[TBL] [Abstract][Full Text] [Related]
17. Ngly1 -/- rats develop neurodegenerative phenotypes and pathological abnormalities in their peripheral and central nervous systems.
Asahina M; Fujinawa R; Nakamura S; Yokoyama K; Tozawa R; Suzuki T
Hum Mol Genet; 2020 Jun; 29(10):1635-1647. PubMed ID: 32259258
[TBL] [Abstract][Full Text] [Related]
18. Aspartylglycosamine is a biomarker for NGLY1-CDDG, a congenital disorder of deglycosylation.
Haijes HA; de Sain-van der Velden MGM; Prinsen HCMT; Willems AP; van der Ham M; Gerrits J; Couse MH; Friedman JM; van Karnebeek CDM; Selby KA; van Hasselt PM; Verhoeven-Duif NM; Jans JJM
Mol Genet Metab; 2019 Aug; 127(4):368-372. PubMed ID: 31311714
[TBL] [Abstract][Full Text] [Related]
19. NGLY1 Deficiency, a Congenital Disorder of Deglycosylation: From Disease Gene Function to Pathophysiology.
Pandey A; Adams JM; Han SY; Jafar-Nejad H
Cells; 2022 Mar; 11(7):. PubMed ID: 35406718
[No Abstract] [Full Text] [Related]
20. A commentary on 'Patient-derived gene and protein expression signatures of NGLY1 deficiency'.
Suzuki T
J Biochem; 2024 Mar; 175(3):221-223. PubMed ID: 38156787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
